George Kottayil - Dec 19, 2023 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
Director
Signature
/s/ George Kottayil
Stock symbol
ACST
Transactions as of
Dec 19, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 04:08 PM
Previous filing
Oct 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +22.5K $0.00 22.5K Dec 19, 2023 Class A Common Shares 22.5K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant).